At The Liver Meeting® 2026, Andrew Moon, MD, MPH, discussed research revealing gaps between clinician and patient priorities in HCC treatment choice.
Andrew Moon, MD, MPH
Advertisement
Articles by Andrew Moon, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Tambiciclib Combo Shows Activity in Relapsed/Refractory Post-Venetoclax AML
2
BOT+BAL Yields Long-Term Survival in Patients With Refractory MSS mCRC
3
MASLD Raises Liver and Other Cancer Risks, Supporting Selective HCC Surveillance
4
Training, Invasiveness, and Workload Behind Falling Prostate Brachytherapy Use
5